ArticlePharmaceuticals (Basel, Switzerland)2023

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy.

Barbara Ruaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.